Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
98,114,970
-
Share change
-
-1,300,977
-
Total reported value
-
$318,380,561
-
Put/Call ratio
-
33%
-
Price per share
-
$3.24
-
Number of holders
-
138
-
Value change
-
-$1,573,167
-
Number of buys
-
53
-
Number of sells
-
75
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q4 2019
As of 31 Dec 2019,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,114,970 shares.
The largest 10 holders included
BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, Engine Capital Management, LP, BRANDES INVESTMENT PARTNERS, LP, VANGUARD GROUP INC, NORTHERN TRUST CORP, Connor, Clark & Lunn Investment Management Ltd., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and STATE STREET CORP.
This page lists
138
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.